Cambridge Independent features Stemnovate in their latest article:

It takes, on average, about 12 years for a new medicine to reach the market – and the typical cost is an eye-watering £1.2billion.

Only one in 5,000 drugs ever makes it that far. Most of those that reach preclinical testing fail at that stage – 99.9 per cent of them in fact. Of the few that go forward to human testing, only one in five is eventually approved.

Little wonder, then, that there is huge demand for improvements to the drug discovery process.

Find out more about how Stemnovate will change drug development with its liver-on-a-chip technology here >

Leave a Reply

Your email address will not be published. Required fields are marked *